Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma.

× No keyword cloud information.

7 in total

Review 1. New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex').

Authors: G Blackledge
Journal: Br J Cancer Date: 1998 Impact factor: 7.640

2. Schedule-dependent interactions between raltitrexed and cisplatin in human carcinoma cell lines in vitro.

Authors: Y Kano; M Akutsu; K Suzuki; Y Yazawa; S Tsunoda
Journal: Jpn J Cancer Res Date: 2000-04

3. Oxaliplatin Eluting CalliSpheres Microspheres for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma.

Authors: Yonghua Bi; Kewei Ren; Jianzhuang Ren; Ji Ma; Xinwei Han
Journal: Front Pharmacol Date: 2022-08-11 Impact factor: 5.988

4. Clinical Outcomes of Drug-Eluting Bead Transarterial Chemoembolization Loaded with Raltitrexed for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma.

Authors: Yonghua Bi; Dechao Jiao; Jianzhuang Ren; Xinwei Han
Journal: Can J Gastroenterol Hepatol Date: 2022-08-23

5. Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.

Authors: M Mabed; L El-Helw; S Shamaa
Journal: Br J Cancer Date: 2004-01-12 Impact factor: 7.640

6. Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma.

Authors: Z Guan; Y Wang; S Maoleekoonpairoj; Z Chen; W S Kim; V Ratanatharathorn; W H H Reece; T W Kim; M Lehnert
Journal: Br J Cancer Date: 2003-11-17 Impact factor: 7.640

7. Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest.

Authors: Hongwei Zhao; Yubao Zhang; Jianmin Sun; Chao Zhan; Liang Zhao
Journal: Oncol Res Date: 2016 Impact factor: 5.574

7 in total